Medtech Matters
Un podcast de Medical Product Outsourcing
155 Épisodes
-
Should Wellness Products Come with a Warning?
Publié: 11/09/2025 -
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees
Publié: 25/06/2025 -
Why Are One-Third of MAUDE Reports a Problem?
Publié: 10/06/2025 -
FDA Guidance on Off-Label Communication, Part 1
Publié: 30/05/2025 -
FDA Guidance on Off-Label Communication, Part 2
Publié: 30/05/2025 -
Development Considerations for Over-the-Counter Medtech, Part 1
Publié: 23/01/2025 -
Development Considerations for OTC Medtech, Part 2
Publié: 23/01/2025 -
Device Descriptions in Regulatory Submissions
Publié: 07/01/2025 -
Regulatory Ramifications Due to the Presidential Election
Publié: 26/11/2024 -
Regulatory Considerations with an Assisted Suicide Machine
Publié: 20/11/2024 -
Predetermined Change Control Plans, Part 2
Publié: 24/09/2024 -
Predetermined Change Control Plans, Part 1
Publié: 24/09/2024 -
What is a CAPA and How Do You Best Use It?
Publié: 03/09/2024 -
You Got a 483 from the FDA. Now what?
Publié: 22/08/2024 -
Revisiting Real-World Evidence
Publié: 18/06/2024 -
The Most Dangerous Devices to Hit the Market
Publié: 11/06/2024 -
Headline-Generating Medical Device Safety Concerns
Publié: 02/05/2024 -
Analyzing ECRI’s 2024 Top 10 Health Technology Hazards
Publié: 19/03/2024 -
Examining Institutional Review Boards
Publié: 06/03/2024 -
Reimbursing Breakthrough Designation Products
Publié: 02/01/2024
A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.
